A #Mizzou researcher has successfully shown how click chemistry can be used to more efficiently deliver drugs to treat tumors in large dogs with bone cancer — a process that had previously only been successful in small mice.
Read more. ⤵️ https://t.co/j3egCnCgjV
@RJYanezMunoz MU was founded in 1839 and each year a class of distinguished students are inducted into Mizzou 1839 (18 grad students; 39 undergrads). https://t.co/Z9hNuick12
My team is growing, I am hiring for a full-time research associate. Pls share: https://t.co/X7XuoAgBQK You’ll be a part of an amazing team with opportunities to collaborate with computational, analytical, high throughput production, and synthetic biology groups!
MyoGene Bio has received a $3.4 million grant from the California Institute of Regenerative Medicine to advance its pre-clinical gene-editing studies in Duchenne, thanks to support from PPMD, @DuchenneUK, and other organizations.
https://t.co/h7T8yVpnAv
Thanks Kristen. The MU communications team was great and Susan @CMTRF did an amazing job detailing her journey with CMT1A. @Mizzou A real pleasure to work with a great team. 🐯 🧬 🔬
CMT research in action! On a recent trip to the University of Missouri, Dr. Chris Lorson showed Susan, our CEO, several #CMT cells through the microscope in his CMT lab.
Find out more about both Dr. Lorson’s #research projects: https://t.co/QWlisJp4fW
#cmtresearchfoundation
Excited to share our new #SMARD1 paper detailing novel patient-based models of disease. Congrats to the entire team!
Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects https://t.co/p6Wixne8S8